目的：比较经口机器人手术（TORS）与非机器人手术（NRS）治疗舌根肿瘤的疗效。方法：根据手 术方式不同，将 45 例舌根肿瘤患者分为 TORS 组（n=19）和 NRS 组（n=26），对比分析两组患者的手术指标及术 后并发症情况。结果：与 NRS 组相比，TORS 组手术时间更短、出血量更少、术后住院天数更短，术后复发率更 低。术后 30 d 内，NRS 组患者吞咽困难、开口受限等并发症发生率高于 TORS 组，差异有统计学意义（P<0.05）。 结论：TORS 治疗舌根肿瘤具有术中出血少、损伤小、术后住院时间短、术后恢复快等微创优势。

Objective: To compare the efficacy of transoral robotic surgery (TORS)and non-robotic surgery (NRS) in the treatment of tongue base tumors. Methods: A total of 45 patients with tongue base tumors treated in our hospital were selected, and they were divided into the TORS group and NRS group according to different surgical methods. The surgical indicators and postoperative complications of patients in the two groups were compared and analyzed. Results: Compared with the NRS group, the operative time, bleeding volume and length of hospital stay were less in the TORS group, and the postoperative recurrence rate was less in the TORS group than that in the NRS group. The incidence rate of dysphagia and restricted mouth opening in the TORS group was lower than that in the NRS group within 30 d after surgery, and the difference was statistically significant (P<0.05). Conclusion: TORS has better minimally invasive advantages in the treatment of tongue base tumors, including less intraoperative bleeding, smaller trauma, shorter length of hospital stay and faster recovery.

收稿日期：2023-03-27  录用日期：2023-11-29 

Received Date: 2023-03-27  Accepted Date: 2023-11-29 

基金项目：军队课题（LB201211AO10038） Foundation Item: Army Project (LB201211AO10038) 

通讯作者：席庆，Email：xiqing301@163.com 

Corresponding Author: XI Qing, Email: xiqing301@163.com 

引用格式：于文俊，林权泉，冯琳，等 . 经口机器人与非机器人手术治疗舌根肿瘤的疗效对比 [J]. 机器人外科学杂志（中英文）， 2024，5（5）：952-958. 

Citation: YU W J, LIN Q Q, FENG L, et al. Comparative study on the efficacy of transoral robotic surgery and non-robotic surgery for tongue base tumors [J]. Chinese Journal of Robotic Surgery, 2024, 5(5): 952-958.

[1] Philippe G. A contemporary review of evidence for transoral robotic surgery in laryngeal cancer[J]. Frontiers in Oncology, 2018. DOI: 10.3389/fonc.2018.00121. 

[2] Mcleod I K, Mair E A, Melder P C. Potential applications of the da vinci minimally invasive surgical robotic system in otolaryngology[J]. Ear Nose Throat J, 2005, 84(8): 483-487. 

[3] Rinaldi V, Pagani D, Torretta S, et al. Transoral robotic surgery in the management of head and neck tumours[J].Ecancermedicalscience, 2013, 7(1): 359. 

[4] Dowthwaite S A, Franklin J H, Palma D A, et al. The role of transoral robotic surgery in the management of oropharyngeal cancer: a review of the literature[J].ISRN Oncology, 2012, 2012(24): 945162. 

[5] Moore E J, Olsen K D, Kasperbauer J L. Transoral robotic surgery for oropharyngeal squamous cell carcinoma: a prospective study of feasibility and functional outcomes. [J].Laryngoscope, 2010, 119(11): 2156-2164. 

[6] Almeida J R D, Genden E M. Robotic surgery for oropharynx cancer: promise, challenges, and future directions[J].Current Oncology Reports, 2012, 14(2): 148-157. 

[7] Weinstein G S, O’Malley, Bert W, et al. Transoral robotic surgery for advanced oropharyngeal carcinoma[J]. Arch Otolaryngol Head Neck Surg, 2010, 136(11): 1079. 

[8] Sharma A, Patel S, Baik F M, et al. Survival and gastrostomy prevalence in patients with oropharyngeal cancer treated with transoral robotic surgery vs chemoradiotherapy[J]. JAMA Otolaryngol Head Neck Surg, 2016, 142(7): 691-697. 

[9] Mercante G, Ruscito P, Pellini R, et al. Transoral robotic surgery (TORS) for tongue base tumours[J].Acta Otorhinolaryngologica Italica, 2013, 33(4): 230-235. 

[10] Mcleod I K, Melder P C. Da Vinci robot-assisted excision of a vallecular cyst: a case report.[J].Ear Nose & Throat Journal, 2005, 84(3): 170-172. 

[11] O’Malley B W, Weinstein G S, Snyder W, et al. Transoral robotic surgery (TORS) for base of tongue neoplasms[J].The Laryngoscope, 2006.DOI: 10.1097/01.mlg.0000227184.90514.1a. 

[12] Kayhan F T, Yigider A P, Koc A K, et al. Treatment of tongue base masses in children by transoral robotic surgery[J].European Archives of Oto-Rhino-Laryngology, 2017, 274(9): 3457-3463. 

[13] Yeh DH, Tam S, Fung K, et al. Transoral robotic surgery vs. radiotherapy for management of oropharyngeal squamous cell carcinoma-A systematic review of the literature[J].European Journal of Surgical Oncology, 2015, 41(12): 1603-1614. 

[14] Möckelmann N, Busch C J, Münscher A,, et al. Timing of neck dissection in patients undergoing transoral robotic surgery for head and neck cancer[J]. Eur J Surg Oncol, 2015, 41(6): 773-778. 

[15] Loon J W L V, Smeele L E, Hilgers F J M, et al. Outcome of transoral robotic surgery for stage I-II oropharyngeal cancer[J].European Archives of Oto-Rhino-Laryngology, 2014, 272(1): 175-183. 

[16] Chia S H, Gross N D, Richmon J D. Surgeon Experience and complications with transoral robotic surgery (TORS)[J]. Otolaryngology-Head and Neck Surgery, 2013, 149(6): 885-892. 

[17] Dabas S, Dewan A, Ranjan R, et al. Transoral robotic surgery in management of oropharyngeal cancers: a preliminary experience at a tertiary cancer centre in India[J].International Journal of Clinical Oncology, 2014, 20(4): 693-700. 

[18] Smith R V, Schiff B A, Garg M, et al. The impact of transoral robotic surgery on the overall treatment of oropharyngeal cancer patients[J]. Laryngoscope, 2015.DOI: 10.1002/lary.25534. 

[19] Dziegielewski P T, Teknos T N, Durmus K. Transoral robotic surgery for oropharyngeal cancer: long-term quality of life and functional outcomes [J]. JAMA Otolaryngol Head Neck Surg, 2013, 139(11): 1099-1108. 

[20] Sethi R K V, Chen M M, Malloy K M. Complications of transoral robotic surgery[J].Otolaryngologic Clinics of North America, 2020, 53(6): 1109-1115. 

[21] Hay A, Migliacci J, Karassawa Zanoni D, et al. Haemorrhage following transoral robotic surgery[J]. Clin Otolaryngol, 2018, 43(2): 638-644. 

[22] Su H K, Ozbek U, Likhterov I, et al. Safety of transoral surgery for oropharyngeal malignancies: an analysis of the ACS NSQIP[J].The Laryngoscope, 2016, 126(11): 2484-2491. 

[23] Kubik M, Mandal R, Albergotti W, et al. Effect of transcervical arterial ligation on the severity of postoperative hemorrhage after transoral robotic surgery[J].Head & Neck, 2017, 39(Suppl 1): 1510- 1515. 

[24] Sharbel D, Abkemeier M, Sullivan J, et al. Transcervical arterial ligation for prevention of postoperative hemorrhage in transoral oropharyngectomy: systematic review and meta-analysis [J]. Head & Neck, 2021, 43(1): 334-344. 

[25] Gleysteen J, Troob S, Light T, et al. The impact of prophylactic external carotid artery ligation on postoperative bleeding after transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma[J].Oral Oncology, 2017.DOI: 10.1016/ j.oraloncology.2017.04.014. 

[26] Mann G, Hankey G J, Cameron D. Swallowing function after stroke: prognosis and prognostic factors at 6 months[J].Stroke, 1999, 30(4): 744-748. 

[27] Finestone H M, Foley N C, Woodbury M G, et al. Quantifying fluid intake in dysphagic stroke patients: a preliminary comparison of oral and nonoral strategies[J].Arch Phys Med Rehabil, 2001, 82(12): 1744-1746.DOI: 10.1053/apmr.2001.27379. 

[28] Smithard D G, O’Neill P A, England R E, et al. The natural history of dysphagia following a stroke[J].Dysphagia, 1997, 12(4): 188-193.